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Cycling glial precursors—‘‘NG2-glia’’—are abundant in the developing and mature central nervous system
(CNS). During development, they generate oligodendrocytes. In culture, they can revert to a multipotent
state, suggesting that theymight have latent stem cell potential that could be harnessed to treat neurodegen-
erative disease. This hope has been subdued recently by a series of fate-mapping studies that cast NG2-glia
as dedicated oligodendrocyte precursors in the healthy adult CNS—though rare, neuron production in the
piriform cortex remains a possibility. Following CNS damage, the repertoire of NG2-glia expands to include
Schwann cells and possibly astrocytes—but so far not neurons. This reaffirms the central role of NG2-glia in
myelin repair. The realization that oligodendrocyte generation continues throughout normal adulthood has
seeded the idea that myelin genesis might also be involved in neural plasticity. We review these develop-
ments, highlighting areas of current interest, contention, and speculation.NG2-glia in Perspective: The Neuron-Glial Dichotomy
The story of NG2-glia begins nearly thirty years ago, with the
discovery of a class of glial precursors—‘‘O-2A progenitors’’—
that could generate oligodendrocytes or type-2 astrocytes in
cultures of perinatal rat optic nerve cells (Raff et al., 1983).
(Two types of glial fibrillary acidic protein [GFAP]-expressing
astrocytes, type-1 and type-2, were recognized in culture; only
type-2 astrocytes arose from O-2A progenitors.) O-2A progeni-
tors express a range of defining molecular markers including
the nerve/glial antigen-2 (NG2, a proteoglycan core protein)
and the platelet-derived growth factor receptor (alpha subunit,
PDGFRa). Using these and other markers, the natural history of
O-2A progenitors began to be revealed. It was shown that
O-2A progenitors first develop in the ventricular germinal zones
of the embryonic spinal cord and brain and disseminate through
the developing CNS by proliferation and migration, becoming
more-or-less uniformly distributed throughout the CNS soon
after birth in rodents (reviewed by Miller, 1996; Richardson
et al., 2006). After birth, O-2A progenitors associate with axons
and generate myelinating oligodendrocytes, which are required
for fast and efficient propagation of action potentials.
Cells with an antigenic phenotype that closely resembled peri-
natal O-2A progenitors were also identified in adult optic nerves
(ffrench-Constant and Raff, 1986; Wolswijk and Noble, 1989).
These behaved as bipotential oligodendrocyte-astrocyte
precursors in culture, just like their perinatal counterparts, but
were found to divide, migrate, and differentiate more slowly
(Wren et al., 1992). The existence of these ‘‘adult O-2A progen-
itors’’ was immediately recognized to have important implica-
tions for the repair of demyelinating damage such as occurs
during multiple sclerosis. Cells that express Pdgfra mRNA,
presumed to correspond to adult O-2A progenitors, were also
visualized throughout the mature brain in situ (Pringle et al.,1992). Thesewere surprisingly numerous—around 5%of all cells
in the CNS (Pringle et al., 1992; Dawson et al., 2003). Using anti-
bodies against NG2 (Stallcup and Beasley, 1987; Diers-Fenger
et al., 2001), a continuous network of NG2 immuno-positive cells
and cell processes was revealed, extending through all parts of
the adult brain and spinal cord (Butt et al., 1999; Ong and Levine,
1999; Nishiyama et al., 1999; Chang et al., 2000; Horner et al.,
2000; Diers-Fenger et al., 2001; Dawson et al., 2003). The abun-
dance and ubiquitous distribution of these NG2+ cells was visu-
ally striking—shocking, even—and they came to be regarded as
a novel ‘‘fifth neural cell type’’ after neurons, oligodendrocytes,
astrocytes and microglia (Nishiyama et al., 1999; Chang et al.,
2000; Butt et al., 2002, 2005; Dawson et al., 2003; Peters,
2004). NG2 and PDGFRa are also expressed by pericytes asso-
ciated with the CNS vasculature (NG2+ and PDGFRa+ pericytes
appear to be distinct). However, double immunolabeling has
shown that PDGFRa+ and NG2+ nonvascular cells are essentially
one and the same population (e.g., Nishiyama et al., 1996; Diers-
Fenger et al., 2001; Dawson et al., 2003; Rivers et al., 2008).
Therefore, in this review we refer to the latter as ‘‘NG2-glia’’ to
distinguish them from pericytes.
In the meantime, attempts to identify type-2 astrocytes in the
developing CNS in vivo had stalled, so a consensus arose that
type-2 astrocytes were an artifact of culture. The term ‘‘O-2A
progenitor’’ gradually passed out of general use and was
replaced by ‘‘oligodendrocyte precursor’’ (OLP) or ‘‘oligoden-
drocyte precursor cell’’ (OPC) to reflect the then-prevailing
view (in the 1990s) that these cells are dedicatedmainly or exclu-
sively to oligodendrocyte production during normal develop-
ment and presumably also in the adult. The nature of type-2
astrocytes and their relationship to real cells in vivo was—and
still is—an interesting conundrum. The relationship between
OLPs in the perinatal CNS and NG2-glia in the adult was alsoNeuron 70, May 26, 2011 ª2011 Elsevier Inc. 661
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cells were descended by lineage from their perinatal counter-
parts this was not formally demonstrated until later, with the
advent of genetic fate-mapping approaches in transgenic mice
(see below). In this article we refer to both the perinatal and adult
cells as NG2-glia.
The sheer number of NG2-glia in the adult brain and their
uniform distribution in both gray and white matter seemed coun-
terintuitive. Given their presumed role as oligodendrocyte
precursors, should they not be concentrated in white matter
where they would presumably be in most demand for myelinat-
ing axons? Why should so many precursor cells persist in the
mature adult brain in any case? Moreover, the complex
process-bearing morphology of NG2-glia in vivo seemed more
in keeping with differentiated cells than immature precursors.
Perhaps NG2-glia served a dual purpose—as a source of oligo-
dendrocytes during development but fulfilling some more
homeostatic or ‘‘functional’’ role in the adult (Nishiyama et al.,
1999; Butt et al., 2002; Wigley et al., 2007; Nishiyama et al.,
2009). Anatomical studies revealed that NG2-glia form close
contacts with neurons—with axons at nodes of Ranvier and in
close proximity to synapses at neuronal cell bodies (Butt et al.,
1999, 2002; Wigley and Butt, 2009). The hypothesis was born
that NG2-glia, or a subset of them, might be involved in some
aspects of information processing, in partnership with neurons.
This idea took off—and NG2-glia became really ‘‘exciting’’—
when electrophysiologists weighed in. It was already known
that NG2-glia express some ion channels and neurotransmitter
receptors and that glutamate can influence their proliferation
and differentiation in culture (Barres et al., 1990; Patneau et al.,
1994; Gallo et al., 1996). However, the first demonstration that
NG2-glia in the hippocampus receive long-range synaptic input
from neurons in vivo sent waves through the research commu-
nity (Bergles et al., 2000). Synaptic communication between
neurons and NG2-glia, both glutamatergic and GABAergic,
was subsequently demonstrated in the cerebellum and cerebral
cortex, both in gray and white matter (Lin and Bergles, 2002;
Chittajallu et al., 2004; Ka´rado´ttir et al., 2005; Lin et al., 2005;
Salter and Fern, 2005; Paukert and Bergles, 2006; Kukley
et al., 2007; Ziskin et al., 2007; Hamilton et al., 2009). Physical
synapses were identified between NG2 glia and unmyelinated
axons in the corpus callosum (Kukley et al., 2007; Ziskin et al.,
2007). Some NG2-glia were found to display spiking sodium
currents in response to an initial depolarization (Chittajallu
et al., 2004; Ka´rado´ttir et al., 2008; Mangin et al., 2008; De Biase
et al., 2010). Suddenly, NG2-glia appeared exotic, ambiguous—
glial in form (since they do not possess axons) but with some
electrical properties akin to neurons. Their chimeric nature also
contributed to the idea that NG2-glia, in their ‘‘other’’ role as
precursor cells, might be more malleable than previously imag-
ined and perhaps capable of transforming into neurons as well
as glia.
NG2-glia as Multipotent Neural Stem Cells?
One study in particular launched the idea of NG2-glia as latent
neural stem cells. This was the demonstration that NG2-glia puri-
fied from early postnatal (P6) rat optic nerves can apparently be
reprogrammed into multipotent stem cells by first treating with662 Neuron 70, May 26, 2011 ª2011 Elsevier Inc.fetal calf serum (FCS) or bone morphogenetic proteins (BMPs)
to generate type-2 astrocytes, followed by growth in basic fibro-
blast growth factor (bFGF) to generate free-floating balls of
cells (neurospheres) containing neural stem cells (Kondo and
Raff, 2000). Individual cells from these neurospheres could
give rise to colonies containing a mixture of neurons, astrocytes,
and oligodendrocytes, judged by immunolabeling with cell
type-specific antibodies (Kondo and Raff, 2000). This study
suggested that NG2-glia are more plastic than previously
believed and suggested an explanation for previous reports
that newborn rat optic nerve cells can generate neurons in
culture, even though optic nerves do not normally contain
neurons (Omlin and Waldmeyer, 1989).
These developments took place against a backdrop of ex-
ploding interest in stem cells of all sorts and neural stem cells
in particular. A landmark series of papers had shown that sube-
pendymal astrocytes (‘‘type-B cells’’) in the subventricular zone
(SVZ) of the adult rodent forebrain are in fact neural stem cells
that generate migratory neuroblasts (‘‘type-A cells’’) destined
for the olfactory bulb (Doetsch et al., 1999). These neuroblasts
follow the ‘‘rostral migratory stream’’ (RMS) from the SVZ to
the olfactory bulb, where they differentiate into new olfactory
interneurons of various types throughout adult life. It seemed
(and still seems) possible that the type-2 astrocytes formed by
culturing optic nerve NG2-glia with FCS or BMPs (Kondo and
Raff, 2000)might be functionally analogous to the subependymal
astrocytes (stem cells) of the SVZ. SVZ stem cells, hippocampal
stem cells, and cultured type-2 astrocytes all express the glial
fibrillary acidic protein (GFAP), for example, and all generate
neurosphere-like bodies when cultured in the presence of
bFGF. Subsequent reports that SVZ stem cells and their imme-
diate progeny express NG2 and PDGFRa—as also do type-2
astrocytes—lent support to this interpretation (Belachew et al.,
2003; Aguirre and Gallo, 2004; Jackson et al., 2006). Taken
together, these observations implied that SVZ stem cells,
type-2 astrocytes and parenchymal NG2-glia might all be close
relatives.
The world of glia was up-ended. No longer were glial cells
simply the ‘‘support cells of neurons’’ but rather the precursors
of neurons, with neuron-like character of their own. Revolu-
tionary ideas need firm foundations, so several labs geared
up to test the differentiation fates of NG2-glia directly in vivo,
using Cre-lox technology in transgenic mice. The first wave of
such studies is now published and the conclusion is clear, if
chastening: by far the most common differentiation products of
parenchymal NG2-glia are oligodendrocytes, both in the normal
and injured adult CNS. Some NG2-expressing cells produce
astrocytes during embryonic development but not in the normal
adult CNS. In the damaged CNS, the situation is a little more
encouraging; following focal demyelination, for example, NG2-
glia can generate remyelinating Schwann cells and possibly
some astrocytes in addition to oligodendrocytes. However, the
notion of NG2-glia as neuronal precursors has taken a significant
blow. Although NG2-glia have some limited lineage plasticity—
a source of continuing optimism for therapeutic applications—
they are, by and large, precursors of myelinating cells. This shifts
attention back to the therapeutic potential of NG2-glia in demy-
elinating conditions such as multiple sclerosis and spinal cord
Neuron
Reviewinjury. It also raises a raft of intriguing new questions concerning
the role of myelination during normal adulthood.
Cre-lox Fate Mapping: Potential Pitfalls
The general principles of Cre-lox fate mapping are as follows.
Mice expressing Cre recombinase under transcriptional control
of a gene that is active in NG2-glia (e.g., Pdgfra, NG2, Olig2,
Plp1) are generated by conventional transgenesis using a
plasmid or bacterial artificial chromosome (BAC) or else by
homologous recombination in ES cells (knockin). These are
crossed with a Cre-conditional reporter line—e.g., Rosa26-lox-
STOP-lox-GFP, where Rosa26 is a ubiquitously active promoter,
lox the recognition site for Cre recombinase, STOP a series of
four cleavage/polyadenylation sites (which effectively stop
mRNA production) and GFP a cassette encoding green fluores-
cent protein. In double-transgenic offspring (e.g., NG2-Cre:
Rosa26-GFP), Cre-driven recombination within the reporter
transgene activates expression of GFP irreversibly in NG2-ex-
pressing cells and all of their descendants, which are identified
retrospectively by immunolabeling for GFP together with cell
type-specific markers. This version of the technique, using stan-
dard Cre, labels NG2-glia as they come into existence during
early development and therefore labels all of the progeny of
NG2-glia up to the time of analysis. An important modification
is to use CreER*, a fusion between Cre and a mutated form of
the estrogen receptor (ER*) that no longer binds estrogen at
high affinity but can bind 4-hydroxy tamoxifen (4HT), ametabolite
of the anti-cancer drug, tamoxifen. After binding 4HT, CreER*
translocates from the cytoplasm (where unliganded ER is nor-
mally sequestered) to the nucleus, triggering recombination
and reporter gene activation. This version of the technique allows
NG2-glia to be labeled inducibly (by administering tamoxifen or
4HT to themice) at a defined stage of development or adulthood,
and the course of division and differentiation of the NG2-glia
charted subsequently (Figure 1).
While this sounds straightforward, there are pitfalls. First
among these is the transcriptional specificity of the Cre trans-
gene, which rarely if ever targets exclusively the precursor cells
of interest. Ideally, one should compare and integrate data
from independent mouse lines that express Cre (or CreER*)
under different transcriptional control—e.g., under either Pdgfra
or NG2 control in the present context of NG2-glia. Another tech-
nical issue relates to the kinetics of Cre recombination—this
depends on the structure of the reporter transgene (e.g.,
distance between lox sites) as well as the level and duration of
Cre expression. Often, a larger proportion of the target cell pop-
ulation can be labeled using a ‘‘good recombiner’’ like Rosa26-
YFP (Srinivas et al., 2001) compared to a ‘‘poor recombiner’’
like Rosa26-eGFP (Mao et al., 2001). The commonly used
Z/EG (Novak et al., 2000) and Rosa26-LacZ (Soriano, 1999) lie
somewhere between these. There seems to be a threshold of
Cre expression, below which very little recombination of the
reporter gene occurs; this threshold is lower for a good re-
combiner than a poor recombiner. This effect can introduce
additional cell-type selectivity; for example, if a given mouse
line expresses Cre in two types of cell, but more highly in one
than the other, then reporter gene activation can effectively be
restricted to the more highly-expressing cells. This can be usefulin some circumstances; for example, it is probably the reason
that Olig2-CreER* drives recombination and reporter gene acti-
vation mainly in NG2-glia and not in differentiated oligodendro-
cytes (Dimou et al., 2008). However, in other situations it might
introduce unwanted bias, e.g., by subdividing the NG2-glia pop-
ulation in some unpredictable way. In short, Cre-lox fate
mapping studies need to be interpreted with care and an open
mind, each study considered on its own merits.
It is worth noting here that differences in the tamoxifen induc-
tion protocol—whether tamoxifen or 4HT is used, whether it is
administered by injection or gavage, or whether it is adminis-
tered once or several times, for example—can also affect the
efficiency of recombination independently of the reporter mouse
line employed. While this will result in a greater or lesser fraction
of NG2-glia becoming labeled, it will have no effect on the level of
expression of the reporter in individual cells because that is
determined purely by regulatory elements in the reporter trans-
gene itself. The flip side of this is that the reporter transgene
(e.g., Rosa26-based) is not necessarily expressed to the same
high level in all cell types, which in principle could lead to
under-estimation of certain cell types among the labeled
progeny of NG2-glia, although there is no evidence that this
has been a problem in the studies reviewed below.
NG2-glia GenerateOligodendrocytes but Not Astrocytes
during Normal Adulthood
Initially, constitutively active Cre was used in NG2-Cre BAC
transgenic mice to label the progeny of NG2 glia during brain
and spinal cord development (Zhu et al., 2008a, 2008b). As ex-
pected, a large proportion of myelinating oligodendrocytes
was found among the GFP-labeled progeny of perinatal NG2-
glia. In addition, significant populations of GFP-labeled proto-
plasmic astrocytes were found in the gray matter of the ventral
forebrain and spinal cord, though not in white matter. No other
labeled cells were identified—in particular, no neurons. A
follow-up study from the same group, usingNG2-CreER* instead
of NG2-Cre, allowed the progeny of NG2-glia to be traced in the
postnatal as well as the embryonic brain (Zhu et al., 2011). When
tamoxifen was administered at embryonic ages (E16.5), a similar
result was obtained as before—NG2-glia generated mainly
oligodendrocytes but also some protoplasmic astrocytes in
ventral brain territories. Using a reporter line (Z/EG) that recom-
bines inefficiently, Zhu et al. (2011) labeled a sparse subset of
embryonic NG2-glia that over time generated discrete clusters
(presumed clones) of sibling cells. They found that labeled cell
clusters contained either astrocytes or oligodendrocyte lineage
cells but not both, suggesting that different subsets of NG2-
glia in the embryonic CNS are specialized for production of
only ventral astrocytes or only oligodendrocytes. When tamox-
ifen was administered to postnatal mice (P2, P30, or P60)
a different result was obtained—this time no astrocytes were
found among the progeny of NG2-glia—concurring with
previous experience from other labs that had used different
CreER* lines (see below). These data imply that there are two
distinct subtypes of NG2-glia—‘‘astrogenic’’ and ‘‘oligo-
genic’’—in the early developing CNS, the astrogenic population
being depleted during late embryonic development. A feasible
explanation might go as follows. Neuroepithelial precursorsNeuron 70, May 26, 2011 ª2011 Elsevier Inc. 663
Figure 1. Compendium of Images of NG2-glia and Their Differentiated Progeny in Transgenic Mice
(A) Low-magnification epifluorescence image of the cerebral cortex of a P13 Sox10-GFPmouse showing the near-uniform distribution of oligodendrocyte lineage
cells, mainly NG2-glia.
(B) A single NG2-glial cell in the cerebellum of a P45 Pdgfra-CreER* : Rosa26-YFP mouse, identified by intrinsic fluorescence in a vibratome section, dye-filled
through a micropipet with Alexa Fluor 488 to reveal whole cell morphology and imaged by two-photon microscopy (Rivers et al., 2008).
(C) Adye-filledmyelinating oligodendrocyte in the corpus callosumof aPdgfra-CreER* :Rosa26-YFPmouse, inducedwith tamoxifen at P45and examined28days
later (P45 + 28) in the two-photon microscope (Rivers et al., 2008). This adult-born oligodendrocyes has >50 internodes. Reproduced from Rivers et al. (2008).
(D) A myelinating oligodendrocyte in the optic nerve of a Pdgfra-CreER* : Tau-mGFPmouse at P60 + 28. Membrane-tethered mGFP reveals full cell morphology
including the myelin sheaths.
(E) Amyelinating oligodendrocyte in the cortical grey matter of a Pdgfra-CreER* : Tau-mGFPmouse, showingmany short randomly orientated myelin internodes,
contrasting with the multiple aligned internodes in white matter.
(F) Remyelinating oligodendrocytes in a Pdgfra-CreER* : Rosa26-YFP focally-demyelinated spinal cord (Zawadzka et al., 2010). The mice were induced with
tamoxifen on four consecutive days starting atP75, lysolecithin (1% v/v) was injected stereotaxically 4 days after the final dose and the animals were analyzed
3 weeks later by epifluorescence microscopy. Oligodendrocyte cell bodies are visualized with anti-GFP (green) and myelin sheaths with anti-PLP (red). Note that
cytoplasmic YFP is largely excluded from compact myelin, presumably for steric reasons.
(G) Remyelinating Schwann cells within a focal ethidium bromide (0.1% w/v)-induced lesion in Pdgfra-CreER* : Rosa26-YFP spinal cord (Zawadzka et al., 2010).
Schwann cells are visualized by immunolabelling for GFP (green) and the Schwann cell-specific protein Periaxin (red).
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cally to maintain their own numbers while giving rise to prolifera-
tive NG2-glia, which migrate away from the ventricular surface,
generating oligodendrocytes during early postnatal develop-
ment and persisting as oligogenic NG2-glia into adulthood.664 Neuron 70, May 26, 2011 ª2011 Elsevier Inc.Then, just prior to birth, the remaining radial glia transform
directly into astrocytes, expressing NG2 transiently as they do
so; these astrocytes undergo limited cell division and settle in
ventral territories close to their region of origin. Direct trans-
differentiation of radial glia is a normal mode of astrocyte
Neuron
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1991). The given scenario is consistent with a study using Olig2-
CreER*, in which some astrocytes as well as oligodendrocytes
(andmotor neurons) were found among the progeny ofOlig2-ex-
pressing neuropithelial precursors in the embryonic ventral
spinal cord (Masahira et al., 2006).
Whatever the precise sequence of events during prenatal glio-
genesis, it now seems likely that NG2-glia do not generate astro-
cytes during normal healthy adulthood. Several Cre-lox
studies—using Pdgfra-CreER* (two independent lines: Rivers
et al., 2008; Kang et al., 2010), NG2-CreER* (Zhu et al., 2011;
see above), and Olig2-CreER* (Dimou et al., 2008) converge on
that conclusion. While some reporter-positive astrocytes were
observed in the cortical graymatter in theOlig2-CreER* line, their
number did not increase significantly between 8 and 65 days
post-tamoxifen administration, indicating that they were not
generated continuously from dividing NG2-glia (Dimou et al.,
2008). It appears that the Olig2-CreER* transgene is expressed
in some protoplasmic astrocytes in the normal gray matter,
resulting in labeling of some of these in addition to NG2-glia.
A subsequent study from the same lab (Simon et al., 2011)
marked NG2-glia in a different way, by long-term BrdU labeling
of 2- to 3-month-old mice, and confirmed that no astrocytes
were found among their differentiated progeny.
Neuron Genesis from NG2-glia—Fact or Fantasy?
NG2-glia exposed to appropriate environmental signals in
a culture dish appear to revert to a multipotent state, from which
they can generate neurons as well as oligodendrocytes and
astrocytes (Kondo and Raff, 2000). This sparked the widespread
hope that NG2-glia can be a regenerative resource for neurode-
generative diseases that involve neuronal as well as glial loss. A
number of studies have encouraged this hope by describing
neuronogenic properties of NG2-glia in the normal rodent
CNS. For example, NG2-glia in the neocortex and piriform
cortex have been reported to express Doublecortin (Dcx), an
established marker of migratory neuronal progenitors in the
forebrain SVZ/ RMS and hippocampus (Tamura et al., 2007;
Guo et al., 2010). Some NG2+ cells in the piriform cortex have
been found to express Sox2 and Pax6 (Guo et al., 2010), two
more neural stem cell markers. Conversely, SVZ and hippo-
campal stem cells have been reported to express NG2
(Belachew et al., 2003; Aguirre and Gallo, 2004) and PDGFRa
(Jackson et al., 2006) and to actively transcribe a CNP-GFP
transgene (Belachew et al., 2003; Aguirre and Gallo, 2004;
Aguirre et al., 2004). However, not all of these observations
have survived scrutiny. For example, other labs have failed to
confirm NG2 or PDGFRa antibody labeling of SVZ or hippo-
campal stem cells (Komitova et al., 2009) or to detect NG2 or
PDGFRa promoter activity in these stem cell populations in
BAC transgenic mice (Rivers et al., 2008; Zhu et al., 2008a;
Kang et al., 2010). While antibody-labeling experiments are
notoriously difficult and artifact-prone, genetic labeling should
be more predictable—so one might imagine—and therefore
capable of providing an unequivocal answer to the question
‘‘do NG2-glia generate neurons’’? However, Cre-lox fate
mapping studies have still not completely eliminated the contro-
versy around this question.Using Pdgfra-CreER*: Rosa26-YFP mice, our lab found that
although NG2-glia generate predominantly Sox10-positive
oligodendrocyte lineage cells during normal adulthood, some
Sox10-negative, YFP+ cells appeared and accumulated in
layers 2 and 3 of the anterior piriform cortex (aPC) (Rivers
et al., 2008). The cells acquired NeuN reactivity and morpholog-
ically resembled piriform projection neurons. The scale of
neuron genesis was small; we estimated that only 1.4% of
the neurons present in layers 2/3 of the aPC were generated
in the 200 days after P45 (Rivers et al., 2008). Two things
pointed to their being generated continually from precursor
cells: (1) they were not observed until around 1 month after
tamoxifen administration, suggesting that they differentiated
slowly from NeuN-negative precursors and (2) they steadily
increased in number between 28 and 210 days posttamoxifen.
It is difficult to imagine how YFP-labeled PC neurons could
continue to accumulate months after tamoxifen administration
had ceased, unless they were generated from a population of
precursor cells that had recombined the YFP reporter gene at
the time of tamoxifen addition. They could not have been
generated from SVZ stem cells because no YFP+ PC neurons
were found in Fgfr3-CreER*:Rosa26-YFP mice, which marks
all GFAP+ SVZ stem cells and their neuronal progeny in the
olfactory bulb, for example (Rivers et al., 2008; Young et al.,
2010). We were unable to colabel the YFP+ neurons with
BrdU, even after months (100 days) of BrdU exposure via the
drinking water, indicating that they might have formed by direct
transformation of long-term-quiescent precursors. Since we
found that 50% of NG2-glia did not incorporate BrdU over
the same time scale (this is controversial), we suggested that
the new PC neurons were formed by transdifferentiation of
postmitotic NG2-glia (Rivers et al., 2008; Psachoulia et al.,
2009). Another possibility is that the new aPC neurons were
produced from some other pool of Pdgfra-expressing precur-
sors, as yet unidentified. Pdgfra is expressed by large numbers
of cells outside of the CNS so the new neurons could conceiv-
ably originate from precursors that enter the CNS via the
circulatory system. Alternatively, they might be generated from
Pdgfra+ perivascular cells within the CNS. (NG2+, PDGFRb+)
perivascular pericytes have been reported to generate neurons
and glia in culture in response to bFGF (Dore-Duffy et al., 2006),
so it is conceivable that PDGFRa+ pericytes might have similar
stem cell-like properties.
One other study has reported PC neurons from NG2-glia
(Guo et al., 2010). This study used Plp1-CreER*: Rosa26-YFP
mice to follow fates of NG2-glia in the healthy adult CNS. Plp1
is expressed in differentiated oligodendrocytes as well as
NG2-glia, so Guo et al. (2010) could not address questions about
new oligodendrocyte production; however, like Rivers et al.
(2008), they did observe YFP-labeling of PC projection neurons.
Their labeled neurons first became apparent 17 days posttamox-
ifen and increased in number for at least 180 days. Control
experiments using GFAP-CreER*: Rosa26-YFP mice to mark
SVZ stem cells ruled out the possibility that the newly-labeled
PC neurons were SVZ-derived. Thus, there are strong parallels
between the experiments and data of Guo et al. (2010) and our
own (Rivers et al., 2008), except that Guo et al. (2010) described
their neurons in the posterior piriform cortex (pPC) (BregmaNeuron 70, May 26, 2011 ª2011 Elsevier Inc. 665
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in the aPC.
Using their own independently generated line of Pdgfra-
CreER* mice, Kang et al. (2010) failed to detect production of
long-term surviving GFP+ neurons in the PC or elsewhere in
the forebrain. The reason for this difference between their study
and ours (Rivers et al., 2008) is not clear. Since the Pdgfra BACs
used for transgenesis were different (ours contained 55 kb
upstream and 74 kb downstream of the Pdgfra gene, theirs
70 kb upstream and 40 kb downstream) it is conceivable
that they might have inherently different transcriptional speci-
ficity—e.g., our BAC but not theirs might contain a regulatory
element required for expression of the Pdgfra-CreER* transgene
in a particular set ofPdgfra-expressing neuronal precursors. This
presupposes that the putative Pdgfra+ precursors are some-
thing other than NG2-glia, since both Pdgfra-CreER* transgenes
are demonstrably expressed in NG2-glia. Alternatively, it might
depend on where one looks —we quantified piriform neuron
production in the aPC (Bregma levels +0.22 mm to +1.2 mm)
(Rivers et al., 2008 and unpublished), whereas Kang et al.
(2010) examined pPC (Bregma 1.9 mm to +0.5 mm).
Other groups have reported small numbers of reporter-posi-
tive neurons (NeuN+) throughout the forebrain—particularly the
ventral forebrain—at short times after CreER* induction, but dis-
counted these as probably resulting from sporadic CreER*
expression in the neurons themselves (Dimou et al., 2008;
Kang et al., 2010; Guo et al., 2010; Zhu et al., 2011). In one study
YFP+, NeuN+ neurons were observed for only a few days
following 4HT injection into NG2-CreER*: Rosa26-YFP mice
(Zhu et al., 2011), suggesting that these neurons were eliminated
from the CNS after a short time or else became NeuN
negative (or YFP negative). The aPC neurons that we observed
(Rivers et al., 2008) are distinct from these and, whatever their
origin, cannot easily be explained by sporadic activation of the
CreER* transgene in neurons (Kang et al., 2010; Zhu et al.,
2011), or by some aspect of the tamoxifen protocol (Simon
et al., 2011).
Further experiments will be required to resolve the ambiguity
around PC neuron genesis. For example, it will be useful to
establish whether there is a real difference between the two
Pdgfra-CreER* lines (Rivers et al., 2008; Kang et al., 2010). If
there is, then differences in the transcriptional specificity of the
two transgenes might give clues to the origin of the PC neurons
observed by Rivers et al. (2008). The transcriptional specificity of
the Plp1 promoter-proximal fragment used in Plp1-CreER*
(Guo et al., 2010) also needs to be examined. This is a fragment
of the Plp1 gene (2.4 kb of 50 sequence plus exon1 and intron1)
(Doerflinger et al., 2003), and it cannot be assumed to exactly
mimic endogenous Plp1 expression—which itself is not entirely
oligodendrocyte lineage specific, being expressed in a subset
of multipotent precursors during development (Delaunay et al.,
2009; Guo et al., 2009; Kang et al., 2010) as well as in some
differentiated neurons (Nery et al., 2001; Miller et al., 2009).
This potentially complicates interpretation of fate mapping
studies (Guo et al., 2009, 2010). It is quite important to get to
the bottom of these discrepancies because, at the very least, it
will refine our understanding of the Cre-lox system and its poten-
tial shortcomings.666 Neuron 70, May 26, 2011 ª2011 Elsevier Inc.In any case, there seems to be something interesting going on
in the PC. There has been a steady trickle of evidence for
neuronal progenitors/immature neurons residing there. For
example, cells in the PC have been reported to express Double-
cortin, polysialated NCAM, Sox2, and other markers of neural
precursor cells (Seki and Arai, 1991; Hayashi et al., 2001; Nacher
et al., 2001, 2002; Pekcec et al., 2006; Shapiro et al., 2007;
Bullmann et al., 2010; Guo et al., 2010). There have also been
reports of continued neuron genesis in the adult rodent and
primate PC and its modulation by olfactory stimulation (Bernier
et al., 2002; Pekcec et al., 2006; Shapiro et al., 2007; Arisi
et al., 2011). Another possibility is that the immature neuron
markers might be indicative of neuronal de-differentiation and
remodeling in response to changing inputs from the olfactory
bulb (OB) (Seki and Arai, 1993; Nacher et al., 2001), since
the aPC (otherwise known as the primary olfactory cortex)
is the primary target for output neurons (mitral cells) of the OB.
The internal OB circuitry is continually changing throughout life,
due to the addition of new OB interneurons from the SVZ, so
perhaps the whole olfactory system including the aPC is in
a constant state of flux.
Do NG2-glia Generate Reactive Astrocytes after Injury?
NG2-glia are known to react to injury by proliferating, upregulat-
ing NG2 expression and generating remyelinating oligodendro-
cytes when required (reviewed by Levine et al., 2001). Since their
differentiation potential is known to be influenced by their
environment in vitro (Kondo and Raff, 2000), it is possible that
they might display a broader range of fates following CNS
injury or disease, when their microenvironment is likely to be
altered by inflammatory cells and possibly through breach of
the blood-brain barrier. Therefore, it is of great interest to
discover the fates of NG2-glia in various experimental models
of disease or traumatic injury.
There has now been a handful of genetic fate mapping studies
of NG2-glia during various experimental pathologies in mice.
These include experimental autoimmune encephalomyelitis
(EAE) (Tripathi et al., 2010), acute gliotoxin-induced focal demy-
elination (Zawadzka et al., 2010), spinal cord section (Barnabe´-
Heider et al., 2010), cortical stab wound (Dimou et al., 2008;
Komitova et al., 2011), and a mouse model of inherited amyotro-
phic lateral sclerosis (ALS; motor neuron disease) (Kang et al.,
2010). All these studies found that NG2-glia respond to injury
by proliferating and accumulating at the site(s) of damage, and
that their major differentiation products are new oligodendro-
cytes. In addition to oligodendrocytes, modest astrocyte
production was also reported in some but not all of these
studies—the main source of reactive astrocytes being preexist-
ing astrocytes, not NG2-glia. One study does not conform to this
pattern. This is a study of cell generation following a cold-
induced injury to the cerebral cortex (Tatsumi et al., 2008), in
which the major product of NG2-glia appeared to be proto-
plasmic ‘‘bushy’’ astrocytes, not oligodendrocytes (see below).
NG2-glia derived neurons were not found in any of these studies,
however. The main features of all the fate-mapping studies
discussed in this review are summarized in Table 1.
Following a cortical (gray matter) stab injury in adult Olig2-
CreER*: Z/EGmice, Dimou et al. (2008) reported oligodendrocyte
Table 1. Summary of Cre-lox Fate-Mapping Studies Discussed in this Article
CreER* Inducer Reporter Condition
% of NG2-glia
Labeled
Cell Types Generated
OL AS N Other
Pdgfraa tam R-YFP normal 45–50 +++  + (aPC)
Pdgfrab 4HT Z/EG normal 40–45 +++  
R-YFP normal 90 nd nd 
Z/EG ALS (SC) ? +++  
Pdgfrac tam R-YFP EAE (SC) 30 +++ +/ 
Pdgfrad tam R-YFP focal demyelination 40 +++ +/  Schwann cells
NG2e 4HT Z/EG normal <2 +++  
R-YFP normal 45 +++  
NG2f 4HT Z/EG cortical stab <2 +++ +/ nd
Olig2g tam Z/EG+R-GFP normal ? +++ +/ 
Z/EG+R-GFP cortical stab ? +++ +/ 
Olig2h 4HT R-GAP43-GFP cryoinjury ?  + 
Olig2i tam R-LacZ, R-YFP axotomy (SC) 40 +++  
Plp1j tam R-YFP normal 10 nd nd + (pPC)
R-YFP, Rosa26-YFP etc. (see text for references); SC, spinal cord; ALS, amyotrophic lateral sclerosis; aPC, anterior piriform cortex; pPC posterior piri-
form cortex; OL, oligodendrocyte lineage; AS, astrocytes; N, neurons; nd, not done. +/ indicates that some astrocytes were found but that thesewere
infrequent (<5% of reporter-positive cells) and/or could be explained by recombination in a subset of astrocytes soon after tamoxifen administration.
a Rivers et al. (2008).
b Kang et al. (2010).
c Tripathi et al. (2010).
d Zawadzka et al. (2010).
e Zhu et al. (2011).
f Komitova et al. (2011).
gDimou et al. (2008).
h Tatsumi et al. (2008).
i Barnabe´-Heider et al. (2010).
j Guo et al., (2010).
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of GFAP+ BrdU+ reactive astrocytes was found in the vicinity of
the lesion, as expected, but these were mostly reporter-negative
(i.e., not NG2-glia derived). Very similar results to these were re-
ported following cortical stab wounds in NG2-CreER*: Rosa26-
YFP mice (Komitova et al., 2011). A subsequent BrdU fate
mapping study (Simon et al., 2011) failed to find evidence for
any astrocyte production from dividing NG2-glia after cortical
stab injury. The emerging consensus from these studies is that
the reactive (hypertrophic, strongly GFAP+) astrocytes that form
the glial ‘‘scar’’ around sites of injury in the cortex are derived
predominantly or exclusively from pre-existing astrocytes, not
from NG2-glia. This conclusion has been supported by comple-
mentary experiments in which astrocytes were labeled specifi-
cally by injecting aGLAST-CreER* lentiviral vector into the cortex
of reporter mice, and their fates followed before and after cortical
stab injury (Buffo et al., 2008). Before injury, the labeled astro-
cytes were quiescent (did not incorporate BrdU after a long label)
but, after injury, they started dividing and generated many new
astrocytes, but not other cell types, at the site of the wound.
This also seems to be what happens after spinal cord injury.
Barnabe´-Heider et al. (2010) made a transverse cut through the
dorsal funiculus of the spinal cord, severing the ascending and
descending axon tracts. They observed new oligogenesis but
insignificant astrocyte production from NG2-glia (marked usingOlig2-CreER*), despite a robust astrocytic reaction/gliosis.
Most interestingly, they identified two separate components
of the astrocytic reaction—a localized accumulation of GFAP+
astrocytes at the core of the lesion site in the dorsal funiculus
and a more diffuse accumulation/gliosis around the lesion site
and throughout the spinal cord at the level of the injury. These
two components had different cellular origins; the ‘‘core’’ astro-
cytes were derived from multipotent stem cells in the ependy-
mal zone surrounding the central canal of the cord (labeled
with FoxJ1-CreER*), whereas the ‘‘diffuse’’ astrocytes were
derived from pre-existing astrocytes in the parenchyma
(labeled with Connexin30-CreER*). It is curious that Barnabe´-
Heider et al. (2010) found that all protoplasmic astrocytes in
the spinal cord were Olig2-immunoreactive in their experi-
ments. Despite this, the Olig2-CreER* transgene did not drive
recombination in astrocytes, perhaps because the level of
CreER* expression was below threshold (see above, under
heading ‘‘Cre-lox Fate Mapping: Potential Pitfalls’’). While this
worked out well for Barnabe´-Heider et al. (2010), it does raise
the possibility that Olig2-CreER* might trigger recombination
in astrocytes in addition to oligodendrocyte lineage cells in
some circumstances.
In marked contrast to the above is a study by Tatsumi et al.
(2008), who followed the fates of NG2-glia following freeze-
thaw lesions in the cerebral cortex. They used Olig2-CreER*Neuron 70, May 26, 2011 ª2011 Elsevier Inc. 667
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Barnabe´-Heider et al. [2010]) tomark presumptive NG2-glia prior
to injury and reported a robust proliferative response followed by
production of ‘‘bushy’’ protoplasmic astrocytes between one
and 2 weeks postinjury. Astrocytes appeared to be the major
differentiated product of NG2-glia in this injury model; oligoden-
drocytes were not observed. However, in this study, as in that of
Dimou et al. (2008), Olig2-CreER* triggered recombination in
some protoplasmic astrocytes in addition to NG2-glia in the
uninjured cortex (20% of reporter-positive cells were astro-
cytes at short times after 4HT administration; Tatsumi et al.,
2008). This leaves open the possibility that the reactive astro-
cytes formed after injury were derived from division of pre-exist-
ing astrocytes. Tatsumi et al. (2008) discounted this idea
because they failed to find BrdU-labeled GFAP+ astrocytes
shortly after injury but it is possible that there could have been
a delayedmitogenic response of astrocytes or slow upregulation
of GFAP in previously GFAP-negative astrocytes, either of which
might have obscured a transient population of BrdU+ astrocytes.
Nevertheless, the apparent absence of oligodendrocyte produc-
tion in the experiments of Tatsumi et al. (2008) marks their study
out from the others; perhaps the particular environment of the
freeze-thaw injury, as compared to stab injury for example,
inhibits NG2-glia from differentiating into oligodendrocytes. It is
important to confirm or refute this observation through cryo-
lesioning experiments in different CreER* mouse lines, because
it could perhaps provide a link to late-stage multiple sclerosis
lesions, in which inhibition of oligodendrocyte differentiation is
thought to contribute to remyelination failure.
Other researchers have examined the response of NG2-glia
during experimentally induced demyelination. In a gliotoxin-
induced focal demyelination model, Zawadzka et al. (2010)
found robust remyelination from NG2-glia (labeled using
Pdgfra-CreER*: Rosa26-YFP)—as expected from previous
studies (Redwine and Armstrong, 1998; Watanabe et al., 2002;
Dawson et al., 2003; reviewed by Franklin and ffrench-Constant,
2008; Figure 1F). A small proportion of YFP+ cells were Aqua-
porin-4+ astrocytes (3%), but the great majority of reactive
astrocytes were derived from Fgfr3-expressing cells (ependymal
cells and/or preexisting astrocytes) (Young et al., 2010), because
they were YFP-labeled in Fgfr3-CreER*: Rosa26-YFP mice
(Zawadzka et al., 2010). Schwann cells, the myelinating cells of
the peripheral nervous system (PNS), are commonly found in
remyelinating CNS lesions including some human multiple scle-
rosis lesions. Often these remyelinating Schwann cells surround
blood vessels, which in the past has been taken to suggest that
they enter the CNS from the PNS, using the vessels as a migra-
tion route. However Zawadzka et al. (2010) found that most re-
myelinating Schwann cells (Periaxin+) in their CNS lesions were
YFP+ in Pdgfra-CreER*: Rosa26-YFP mice, suggesting that
they were derived from NG2-glia (Figure 1G). In strong support
of this, the CNS-resident Schwann cells were also labeled in
Olig2-Cre: Rosa26-YFP animals—Olig2 is not thought to be ex-
pressed outside of the CNS. Moreover, almost no CNS Schwann
cells, but many Schwann cells in peripheral nerves, were labeled
in Pzero-CreER*: Rosa26-YFP mice. (Pzero is expressed in
migrating neural crest and differentiated Schwann cells, but
not in the oligodendrocyte lineage.)668 Neuron 70, May 26, 2011 ª2011 Elsevier Inc.Schwann cells were not a minor side product of NG2-glia
because 56% of all YFP+ cells in ethidium bromide-induced
lesions were Periaxin+ Schwann cells. (Despite this, most new
myelin is oligodendrocyte derived, because Schwann cells
each remyelinate only a single internode, whereas oligodendro-
cytes remyelinate many.) To our knowledge, this is the clearest
example to date of lineage plasticity among NG2-glia in vivo.
Since both oligodendrocytes and Schwann cells are myelinating
cells, relatively subtle reprogramming might be required to cross
between them.
In a different demyelinating model—experimental autoim-
mune encephalomyelitis (EAE), which causes more diffuse and
widespread demyelination than gliotoxin injection—Tripathi
et al. (2010) found robust production of NG2-glia-derived oligo-
dendrocytes but very fewSchwann cells. In EAE, there is a strong
inflammatory component to the pathology that is not present in
gliotoxin-induced demyelination, suggesting that the local
microenvironment in demyelinated lesions exerts a strong influ-
ence on the direction of differentiation of NG2-glia. Only a small
fraction of YFP+ cells (1%–2%) were GFAP+ astrocytes in EAE, in
keeping with the results from focal demyelination (Zawadzka
et al., 2010). A relatively high proportion (10%) of YFP+ cells
in this EAE study could not be identified, despite much effort
with antibodies against microglia, macrophages, B or T cells,
neutrophils, vascular endothelial cells, pericytes, neurons, astro-
cytes, oligodendrocytes, and Schwann cells.
No astrocyte production from NG2-glia was detected in
a mouse model of hereditary ALS (Kang et al., 2010), despite
extensive astrocytosis in the ventral horns of the spinal cord
where motor neuron degeneration occurs. These authors did,
however, observe proliferation and accumulation of NG2-glia
and differentiated oligodendrocytes—an unexpected result,
since oligodendrocyte involvement in ALS pathology was not
previously suspected.Whether reactive NG2-glia are specifically
involved in myelin repair in ALS or an incidental byproduct of
tissue damage or inflammation is not known.
The gathering consensus seems to be that NG2-glia remain
largely committed to the oligodendrocyte lineage in the healthy
CNS and in most pathological situations. Exceptions are (1) the
still-unresolved question of low-level neuron genesis in the
piriform cortex during normal adulthood, (2) robust Schwann
cell generation following gliotoxin-induced demyelination, and
(3) production of a few GFAP+ astrocytes in some but not all
injury studies. Overall, lineage flexibility seems to be strongly
biased toward myelinating lineages. This injects a healthy dose
of realism and tempers our hopes for NG2-glia as a panacea
for neurodegenerative disease. It remains possible that NG2-
glia might have the potential to generate neurons but do not
readily reveal that potential in the environment of the damaged
CNS—at least not those conditions that have been examined
so far. Pharmacological interventions that can redirect differenti-
ation toward neurons might be found in the future, but it will not
be an easy fix. On the other hand, the data reaffirm the central
role of NG2-glia in myelin repair, in demyelinating conditions
such as multiple sclerosis or spinal cord injury. It has also been
useful to learn that the great majority of reactive astrocytes are
in most cases not descended from NG2-glia, but from paren-
chymal astrocytes that re-enter the cell cycle and, in the spinal
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cells represent a relatively unexplored population that is a key
target for future investigation. It will be important to discover
whether these cells retain, or can be induced to recapitulate,
some of the neuronogenic flavor of their forebears in the embry-
onic neuroepithelium.
Oligodendrocyte Generation and Myelin Dynamics
in the Adult
Most newly formed oligodendrocytes in the postnatal forebrain
survive long-term and myelinate axons. Myelin formation has
been demonstrated by microinjecting live YFP+ cells in tissue
slices with a fluorescent dye that can spread throughout the
cell and expose its full morphology. Like this, newly-formed
mature oligodendrocytes that elaborate up to 50 internodes
have been visualized in the adult corpus callosum (Rivers
et al., 2008; Figure 1C). Newly formed oligodendrocytes with
myelinating morphology were also identified using reporter
mice that express a membrane-tethered form of GFP (Kang
et al., 2010; Zhu et al., 2011; Figure 1D). That most new oligoden-
drocytes survive long-term (at least in the corpus callosum)
can be inferred by comparing the rate of new cell production
(through division of NG2-glia) with the rate of accumulation
of differentiated oligodendrocytes, given that the absolute
number and density of NG2-glia does not change dramatically
during the first year of life (Psachoulia et al., 2009). The cell
cycle dynamics of NG2-glia is known from cumulative BrdU
labeling experiments (Psachoulia et al., 2009; Simon et al.,
2011; see below).
The scale of adult oligogenesis has been something of
a surprise. Rivers et al. (2008) calculated that 29% of all differ-
entiated oligodendrocytes (identified by CC1 immunolabeling)
that are present in the corpus callosum of 8-month-old mice
are generated in the 210 days after P45 (Pdgfra-CreER*:
Rosa26-YFP). Zhu et al. (2011) found that30% of CC1-positive
oligodendrocytes in the corpus callosum of 4-month-old mice
were formed in the 60 days after P60 (NG2-CreER*: Rosa26-
YFP). Comparing these estimates, one might conclude that no
more oligodendrocytes are formed after 4 months of age, but
Psachoulia et al. (2009) showed clearly that new myelinating
oligodendrocytes are still being formed at a low rate even at
8 months. There are a lot of uncertainties in such calculations,
(e.g., potential variation in recombination efficiencies from
experiment to experiment and at different ages) but, neverthe-
less, it is clear that oligodendrocyte differentiation continues
well into adulthood (Figure 1E), though at a steadily decreasing
rate (Rivers et al., 2008; Lasiene et al., 2009; Psachoulia et al.,
2009; Kang et al., 2010; Simon et al., 2011; Zhu et al., 2011).
NG2-glia in the cortical gray matter also continue to generate
oligodendrocytes into adulthood, although the overall rate of oli-
gogenesis in the cortex is considerably less than in the corpus
callosum at most ages (Rivers et al., 2008; Kang et al., 2010;
Simon et al., 2011; Zhu et al., 2011).
It is not known yet whether adult myelin genesis is required to
replace myelin that degenerates through normal ‘‘wear and tear’’
or whether it adds to existing myelin. Only around 30% of axons
in the corpus callosum of 8-month-old mice are fully myelinated
(Sturrock, 1980), so there is plenty of scope there and in othermajor white matter tracts for de novo myelination of previously
naked axons. There is evidence from cumulative [3H]-thymidine
labeling that oligodendrocytes accumulate modestly in the
mouse corpus callosum during the first year, without significant
turnover, supporting the idea of de novo myelination (McCarthy
and Leblond, 1988). Electron microscopy also shows that the
number of myelinated axons in the rodent corpus callosum
increases well into adulthood (Nun˜ez et al., 2000; Yates and
Juraska, 2007). If adult-born myelin is laid down exclusively on
naked axons, we would expect not to findmany newmyelinating
oligodendrocytes in fiber tracts that consist predominantly of
myelinated axons, such as the optic nerve (Honjin et al., 1977);
this remains to be tested. On the other hand, myelin turnover is
suggested by the observation that average internode length
decreases with age, shorter internodes being regarded as
a hallmark of remyelination following myelin loss (Lasiene et al.,
2009). Perhaps de novo myelination and myelin replacement
go on concurrently in different parts of the CNS or within axon
tracts, such as the corpus callosum, that contain a mixture of
myelinated and unmyelinated axons. If myelin turnover turns
out to be commonplace, how neural pathways can cope with
continual loss and replacement of oligodendrocytes would
need to be understood, because the loss of even one myelin
internode has been predicted to cause conduction block (Koles
and Rasminsky, 1972; Waxman and Brill, 1978; Smith et al.,
1982). Whether action potentials are blocked or delayed will
depend on the geometry of the affected fibers, including inter-
node length and axon diameter (e.g., Bostock and Sears,
1976; Waxman and Brill, 1978; Bakiri et al., 2010). Nevertheless,
given that one oligodendrocyte usually myelinates many axons,
significant problems might be anticipated from oligodendrocyte
turnover. Perhaps new internodes can intercalate between exist-
ing internodes—i.e., remyelination might initiate at nodes of
Ranvier and gradually expand lengthwise, pushing aside the ex-
isting internodal sheath(s) while maintaining continuity of myelin.
This brief discussion exposes gaps in our knowledge of basic
myelin dynamics that need to be filled before we can hope to
understand myelin maintenance and plasticity.
Speculations on the Role of Adult Myelination
in Learning and Memory
Personal experience tells us that learning a complex motor
skill—riding a bicycle, playing a musical instrument, learning
a dance step or a sporting activity—requires a great deal of
time and practice. On the other hand a motor skill, once learned,
is difficult to lose and stays with us throughout our active life. The
extended learning experience and long decay time seem consis-
tent with the production and long-term survival of new cells.
Could new myelin formation during postnatal life play a part in
motor learning? Motor learning is an example of unconscious
or ‘‘nondeclarative’’ learning, which includes habituation and
classical conditioning (e.g., fear conditioning and Pavlovian
conditioning). Nondeclarative learning and memory is an ancient
system that is well developed in invertebrate animals—for
example, the gill retraction reflex that has been studied in Aplysia
and other marine molluscs. Studies of this and related
phenomena have established that even very small nervous
systems have the capacity to learn and remember pastNeuron 70, May 26, 2011 ª2011 Elsevier Inc. 669
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circuits involved in the behavioral response, not something that
is generated or stored remotely (Carew and Sahley, 1986). The
general idea is that, during repetitive use, circuit connectivity
becomes strengthened so that the neurons comprising the
circuit acquire a lower threshold for firing and become more
likely to fire again in future—so-called ‘‘Hebbian learning.’’
How does this happen at a cellular and molecular level? It is
well established that repetitive firing can induce changes to the
molecular composition of the active synapses and that this can
increase the strength of communication between pre-and
post-synaptic cells (Milner et al., 1998). Synaptic strengthening
is an established mechanism of long-term potentiation (LTP),
a cellular correlate of learning and memory in both invertebrates
and vertebrates (Bliss and Collingridge, 1993). With the evolution
of myelin, vertebrates might have acquired an additional way of
modulating circuit activity—by myelinating the interconnecting
axons, if previously unmyelinated. New myelination would be
expected to increase dramatically the speed of transmission of
action potentials and alter the intrinsic circuit properties. Myeli-
nation would also provide neurotrophic and physical support
to the circuit neurons and make for long-term survival.
There is some evidence that adult myelin genesis might
contribute to motor learning in humans. For example, it has
been reported that extensive piano practice (Bengtsson et al.,
2005) or juggling (Scholz et al., 2009) can cause long-term
changes to the structure of white matter tracts, including parts
of the corpus callosum, as revealed by magnetic resonance
imaging (MRI). It has also been reported that white matter struc-
ture is altered in children skilled in abacus use, which involves
actual and imagined visuomotor activity (Hu et al., 2011).
There is also evidence that training in working memory tasks
results in changes in the structure of frontoparietal white
matter (Takeuchi et al., 2010; for reviews see Fields, 2008;
Ulle´n, 2009).
For new myelin to be involved in activity-dependent learning,
there needs to be a mechanism for regulating oligodendrocyte
generation and myelination according to circuit activity. Such
a mechanism seems to exist. Recently, Li et al. (2010) showed
that electrical stimulation of neurons in the motor cortex led to
activity-dependent stimulation of proliferation of NG2-glia in
the descending pyramidal (corticospinal) tract. Previously,
Barres and Raff (1993) had shown that silencing retinal ganglion
neurons, by injecting tetrodotoxin into the developing eye,
inhibited proliferation of NG2-glia in the newborn rat optic nerve.
Inhibition could be overcome by implanting PDGF-expressing
cells next to the nerve, suggesting that electrical activity in retinal
ganglion cell axons might normally regulate the supply of mito-
gens to NG2-glia—possibly by triggering its release from optic
nerve astrocytes (Barres and Raff, 1993). This suggests one
mechanism by which NG2-glia might sense electrical activity,
which, at some threshold, might trigger them to divide and differ-
entiate into myelinating oligodendrocytes. A more direct mecha-
nism involving synaptic communication between axons and
NG2-glia can also be envisaged—for example, synaptic
signaling might regulate the intrinsic response of NG2-glia to
PDGF or othermitogens. Testing these ideaswill be an important
task for the future.670 Neuron 70, May 26, 2011 ª2011 Elsevier Inc.Does the Decreasing Rate of New Myelin Genesis
Contribute to Age-Related Cognitive Decline?
There is an accumulating body of evidence that some measures
of general cognitive ability correlate with white matter volume
and integrity. For example, cognitive ability and white matter
volume increase in parallel into the fourth decade of life and
both decline thereafter (Bartzokis et al., 2001; Mabbott et al.,
2006; Hasan et al., 2008; Ulle´n et al., 2008; Zahr et al., 2009;
Bartzokis et al., 2010). The reasons behind these age-related
changes are unknown but they could conceivably relate to
changes in the ability of NG2-glia to proliferate and generate
new oligodendrocytes as the brain matures and ages.
We recently measured the cell cycle time (Tc) of NG2-glia in
the postnatal mouse brain by cumulative BrdU labeling
(Psachoulia et al., 2009) and reported that Tc increases dramat-
ically with age, from2 days on postnatal day 6 (P6) to >70 days
at P240 (8 months of age) in the cerebral cortex. An age-related
increase in the cell cycle time of NG2-glia in the mouse spinal
cord has also been reported (Lasiene et al., 2009). The length-
ening cell cycle results from the cells’ spending more and
more time in the early G1 phase of the cycle (Geha et al., 2010;
Simon et al., 2011). The decreasing rate of cell division correlates
well with the decreasing rate of oligodendrocyte production with
age (Psachoulia et al., 2009)—as expected, since new oligoden-
drocytes must ultimately come from precursor cell divisions. If
we assume that oligodendrocytes have a long but finite lifetime
in vivo, it could be that as the division rate of NG2-glia deceler-
ates and, with it, the rate of oligodendrocyte production, a critical
age is reached beyond which the rate of new myelin production
does not keep pace with accelerating myelin loss. If so, finding
a way to maintain the proliferative rate of NG2-glia in old
age might help maintain white matter integrity and slow down
age-related mental decline.
Conclusion
Recent experiments indicate that NG2-glia are, first and fore-
most, oligodendrocyte precursors in the healthy adult CNS.
Thus, it is clear that NG2-glia are distinct from neural stem cells
that generate hippocampal or olfactory neurons throughout life.
Whether they can generate rare neurons in the piriform cortex, as
reported by two labs recently, is still unresolved. Following CNS
injury, NG2-glia undergo a burst of local proliferation before
giving rise to oligodendrocytes and possibly some astrocytes.
Following gliotoxin-induced focal demyelination in the spinal
cord, they also generate significant numbers of remyelinating
Schwann cells. The great majority of reactive astrocytes at sites
of damage are not derived from NG2-glia, but from pre-existing
astrocytes that re-enter the cell cycle and—in spinal cord—from
stem-like cells in the ependymal zone around the central canal.
That NG2-glia are mainly precursors of myelinating cells refo-
cuses our attention on the their crucial role in remyelination
following demyelinating disease or injury. We are also drawn to
the role of myelin genesis during normal healthy adulthood,
whichmight play a role in some forms of neural plasticity—motor
skills learning, for example. The fact that NG2-glia react rapidly
to injury suggests that they might also respond to systemic
modulation. Indeed, their cell cycle and/or differentiation rate
can be influenced by prolactin levels during pregnancy (Gregg
Neuron
Reviewet al., 2007) or by physical exercise (Simon et al., 2011). There-
fore, a key research focus for the future is the potential role of
adult myelination in learning and memory and how that might
be affected by the environment.ACKNOWLEDGMENTS
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